Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FVGXQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,882
Award facts
- Contract value 100% obligated
- $6,882.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract, valued at $6,882.10 with a firm fixed price structure, is classified as a non-set-aside competitive award and will be completed by November 7, 2025. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the supplier to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The current award for Zepbound, a diabetes medication, represents a typical delivery order under the company's prime vendor contract structure, which facilitates flexible and timely pharmaceutical support to the federal government's healthcare needs.
Quick answers
Who was awarded contract SPE2DB26FVGXQ?
SPE2DB26FVGXQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FVGXQ worth?
The government has obligated $6,882 on SPE2DB26FVGXQ.
Is contract SPE2DB26FVGXQ an order under another contract?
Yes. SPE2DB26FVGXQ is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB26FVGXQ competed?
The extent of competition for SPE2DB26FVGXQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award